TY  - GEN
AU  - Boyko,A N
AU  - Bosenko,L P
AU  - Vasilovskiy,V V
AU  - Volkova,L I
AU  - Zakharova,M N
AU  - Kotov,S V
AU  - Lekomtseva,E V
AU  - Negrich,T I
AU  - Parshina,E V
AU  - Patrusheva,O P
AU  - Prokopenko,S V
AU  - Sazonov,D V
AU  - Timchenko,L V
AU  - Trinitatskiy,Yu V
AU  - Khabirov,F A
AU  - Khavunka,M Ya
AU  - Chichanovskaya,L V
AU  - Sherman,M A
AU  - Ivanov,R A
AU  - Lin'kova,Yu N
AU  - Stukalina,E Yu
AU  - Zinkina-Orikhan,A V
AU  - Obukhova,I G
TI  - [Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a]
SN  - 1997-7298
PY  - 2019///0826
KW  - Adjuvants, Immunologic
KW  - Humans
KW  - Interferon beta-1a
KW  - therapeutic use
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - drug therapy
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.17116/jnevro20191192273
ER  -